His primary scientific interests are in Antibody, Virology, Epitope, Glycoprotein and Binding site. His Antibody research incorporates themes from Molecular biology, Immune system, Antigen and Cell biology. His study in Virology is interdisciplinary in nature, drawing from both Immunoglobulin G and Immunology.
His studies deal with areas such as Viral envelope and Conserved sequence as well as Epitope. His Glycoprotein research includes themes of Biophysics, Viral entry and Peptide sequence. Richard T. Wyatt interconnects Protein structure, Receptor and Conformational change in the investigation of issues within Binding site.
His scientific interests lie mostly in Virology, Antibody, Glycoprotein, Epitope and Binding site. The Virology study combines topics in areas such as Immunogen and Immunology. His Antibody research incorporates elements of Molecular biology, Immune system and Antigen.
Richard T. Wyatt combines subjects such as V3 loop, Glycosylation and Cell biology with his study of Molecular biology. His Glycoprotein research includes elements of Biophysics, Plasma protein binding, Gp41 and Immunogenicity. His Epitope research incorporates themes from Viral envelope, Envelope glycoprotein GP120, Viral entry, Glycan and Protein structure.
Richard T. Wyatt mainly investigates Virology, Antibody, Glycoprotein, Epitope and Immunogen. In the field of Virology, his study on Neutralization overlaps with subjects such as Trimer. Richard T. Wyatt has researched Antibody in several fields, including Vaccination, Binding site and Glycan.
His study in Glycoprotein is interdisciplinary in nature, drawing from both HIV vaccine, Gp41, Furin and Stereochemistry. His studies link Heterologous with Epitope. His Monoclonal antibody research integrates issues from Molecular biology, Plasma protein binding and B-cell receptor.
Richard T. Wyatt mainly focuses on Virology, Glycoprotein, Antibody, Glycan and Epitope. His work on Neutralization is typically connected to Trimer as part of general Virology study, connecting several disciplines of science. His Glycoprotein study combines topics from a wide range of disciplines, such as Germinal center, Gp41 and Furin.
His studies in Antibody integrate themes in fields like Virus, Plasma protein binding and Molecular biology. His work in Molecular biology covers topics such as Complementarity determining region which are related to areas like Protein structure. His work carried out in the field of Neutralizing antibody brings together such families of science as Titer, T cell, Cell-mediated cytotoxicity, Vaccination and Binding site.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
Peter D. Kwong;Richard Wyatt;James Robinson;Raymond W. Sweet.
The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.
Richard Wyatt;Joseph Sodroski.
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu;Zhi Yong Yang;Yuxing Li;Carl Magnus Hogerkorp.
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
Lijun Wu;Norma P. Gerard;Richard Wyatt;Hyeryun Choe.
The antigenic structure of the HIV gp120 envelope glycoprotein
Richard Wyatt;Peter D. Kwong;Elizabeth Desjardins;Raymond W. Sweet.
A Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding
Carlo D. Rizzuto;Richard Wyatt;Richard Wyatt;Nivia Hernández-Ramos;Nivia Hernández-Ramos;Ying Sun;Ying Sun.
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
Peter D. Kwong;Peter D. Kwong;Michael L. Doyle;Michael L. Doyle;David J. Casper;Claudia Cicala.
HIV vaccine design and the neutralizing antibody problem
Dennis R Burton;Ronald C Desrosiers;Robert W Doms;Wayne C Koff.
Nature Immunology (2004)
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Johannes F. Scheid;Hugo Mouquet;Niklas Feldhahn;Michael S. Seaman.
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
Jason S. McLellan;Marie Pancera;Chris Carrico;Jason Gorman.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: